Researchers develop novel biodegradable nanoprobe to detect diabetic retinopathy in its early stages

In a paper published by the research team of Ali Hafezi-Moghadam, MD, Ph.D. at the Brigham and Women's Hospital (BWH), a founding member of Mass General Brigham, authors introduced a biodegradable fluorescent nanoprobe to detect diabetic retinopathy (DR) in its early molecular stage.